APO Research
Talk to an analyst

APO RESEARCH · REPORT

Edaravone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Edaravone Market Outlook and Growth Opportunities 2026

26 December 2025191 pages

Choose your research edition.

Industry ResearchEdaravone Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Edaravone Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Edaravone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Edaravone Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Edaravone Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Edaravone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Edaravone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Edaravone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Edaravone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Edaravone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Edaravone market include Mitsubishi Tanabe Pharma, Piramal Healthcare, Simcere, Sun Pharmaceutical Industries Ltd., Taj Pharmaceuticals Ltd., UCB India Ltd and Unichem Laboratories Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Edaravone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Edaravone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Edaravone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Edaravone market size, projected growth trends, production technologies, key applications, and end-use industries.

Edaravone Segment by Company

Mitsubishi Tanabe Pharma

Piramal Healthcare

Simcere

Sun Pharmaceutical Industries Ltd.

Taj Pharmaceuticals Ltd.

UCB India Ltd

Unichem Laboratories Ltd

Edaravone Segment by Type

Oral Edaravone

Injection Edaravone

Edaravone Segment by Application

Hospital

Clinic

Others

Edaravone Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Edaravone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Edaravone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Edaravone significant trends, drivers, influence factors in global and regions.

6. To analyze Edaravone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Edaravone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Edaravone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Edaravone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Edaravone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Edaravone industry.

Chapter 3: Detailed analysis of Edaravone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Edaravone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Edaravone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Edaravone Industry Trends Table 2. Edaravone Industry Drivers Table 3. Edaravone Industry Opportunities and Challenges Table 4. Edaravone Industry Restraints Table 5. Global Edaravone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Edaravone Revenue Share by Company (2021-2026) Table 7. Global Edaravone Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Edaravone Sales Volume Share by Company (2021-2026) Table 9. Global Edaravone Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Edaravone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Edaravone Key Company Manufacturing Base & Headquarters Table 12. Global Edaravone Company, Product Type & Application Table 13. Global Edaravone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Edaravone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Edaravone Table 18. Significant Companies of Injection Edaravone Table 19. Global Edaravone Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Edaravone Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Edaravone Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Edaravone Sales Volume Share by Type (2021-2026) Table 23. Global Edaravone Sales Volume Share by Type (2027-2032) Table 24. Global Edaravone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Edaravone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Edaravone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Edaravone Sales Value Share by Type (2021-2026) Table 28. Global Edaravone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Edaravone Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Edaravone Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Edaravone Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Edaravone Sales Volume Share by Application (2021-2026) Table 36. Global Edaravone Sales Volume Share by Application (2027-2032) Table 37. Global Edaravone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Edaravone Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Edaravone Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Edaravone Sales Value Share by Application (2021-2026) Table 41. Global Edaravone Sales Value Share by Application (2027-2032) Table 42. Global Edaravone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Edaravone Sales by Region (2021-2026) & (K Units) Table 44. Global Edaravone Sales Market Share by Region (2021-2026) Table 45. Global Edaravone Sales by Region (2027-2032) & (K Units) Table 46. Global Edaravone Sales Market Share by Region (2027-2032) Table 47. Global Edaravone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Edaravone Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Edaravone Sales Value Share by Region (2021-2026) Table 50. Global Edaravone Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Edaravone Sales Value Share by Region (2027-2032) Table 52. Global Edaravone Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Edaravone Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Edaravone Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Edaravone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Edaravone Sales by Country (2021-2026) & (K Units) Table 57. Global Edaravone Sales Market Share by Country (2021-2026) Table 58. Global Edaravone Sales by Country (2027-2032) & (K Units) Table 59. Global Edaravone Sales Market Share by Country (2027-2032) Table 60. Global Edaravone Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Edaravone Sales Value Market Share by Country (2021-2026) Table 62. Global Edaravone Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Edaravone Sales Value Market Share by Country (2027-2032) Table 64. Mitsubishi Tanabe Pharma Company Information Table 65. Mitsubishi Tanabe Pharma Business Overview Table 66. Mitsubishi Tanabe Pharma Edaravone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Mitsubishi Tanabe Pharma Edaravone Product Portfolio Table 68. Mitsubishi Tanabe Pharma Recent Development Table 69. Piramal Healthcare Company Information Table 70. Piramal Healthcare Business Overview Table 71. Piramal Healthcare Edaravone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Piramal Healthcare Edaravone Product Portfolio Table 73. Piramal Healthcare Recent Development Table 74. Simcere Company Information Table 75. Simcere Business Overview Table 76. Simcere Edaravone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Simcere Edaravone Product Portfolio Table 78. Simcere Recent Development Table 79. Sun Pharmaceutical Industries Ltd. Company Information Table 80. Sun Pharmaceutical Industries Ltd. Business Overview Table 81. Sun Pharmaceutical Industries Ltd. Edaravone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sun Pharmaceutical Industries Ltd. Edaravone Product Portfolio Table 83. Sun Pharmaceutical Industries Ltd. Recent Development Table 84. Taj Pharmaceuticals Ltd. Company Information Table 85. Taj Pharmaceuticals Ltd. Business Overview Table 86. Taj Pharmaceuticals Ltd. Edaravone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Taj Pharmaceuticals Ltd. Edaravone Product Portfolio Table 88. Taj Pharmaceuticals Ltd. Recent Development Table 89. UCB India Ltd Company Information Table 90. UCB India Ltd Business Overview Table 91. UCB India Ltd Edaravone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. UCB India Ltd Edaravone Product Portfolio Table 93. UCB India Ltd Recent Development Table 94. Unichem Laboratories Ltd Company Information Table 95. Unichem Laboratories Ltd Business Overview Table 96. Unichem Laboratories Ltd Edaravone Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Unichem Laboratories Ltd Edaravone Product Portfolio Table 98. Unichem Laboratories Ltd Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Edaravone Distributors List Table 102. Edaravone Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Edaravone Product Image Figure 2. Global Edaravone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Edaravone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Edaravone Sales (2021-2032) & (K Units) Figure 5. Global Edaravone Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Edaravone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Edaravone Image Figure 10. Injection Edaravone Image Figure 11. Global Edaravone Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Edaravone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Edaravone Sales Volume Share by Type (2021-2032) Figure 14. Global Edaravone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Edaravone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Edaravone Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Edaravone Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Edaravone Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Edaravone Sales Volume Share by Application (2021-2032) Figure 23. Global Edaravone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Edaravone Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Edaravone Sales Value Share by Application (2021-2032) Figure 26. Global Edaravone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Edaravone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Edaravone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Edaravone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Edaravone Sales Value (2021-2032) & (US$ Million) Figure 31. North America Edaravone Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Edaravone Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Edaravone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Edaravone Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Edaravone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Edaravone Sales Value (2021-2032) & (US$ Million) Figure 37. South America Edaravone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Edaravone Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Edaravone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Edaravone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Edaravone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Edaravone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Edaravone Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Edaravone Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Edaravone
  • Injection Edaravone
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Mitsubishi Tanabe Pharma
  • Piramal Healthcare
  • Simcere
  • Sun Pharmaceutical Industries Ltd.
  • Taj Pharmaceuticals Ltd.
  • UCB India Ltd
  • Unichem Laboratories Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Edaravone Sales Value (2021-2032)
  4. 1.2.2 Global Edaravone Sales Volume (2021-2032)
  5. 1.2.3 Global Edaravone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Edaravone Market Dynamics
  1. 2.1 Edaravone Industry Trends
  2. 2.2 Edaravone Industry Drivers
  3. 2.3 Edaravone Industry Opportunities and Challenges
  4. 2.4 Edaravone Industry Restraints
3 Edaravone Market by Company
  1. 3.1 Global Edaravone Company Revenue Ranking in 2025
  2. 3.2 Global Edaravone Revenue by Company (2021-2026)
  3. 3.3 Global Edaravone Sales Volume by Company (2021-2026)
  4. 3.4 Global Edaravone Average Price by Company (2021-2026)
  5. 3.5 Global Edaravone Company Ranking (2024-2026)
  6. 3.6 Global Edaravone Company Manufacturing Base and Headquarters
  7. 3.7 Global Edaravone Company Product Type and Application
  8. 3.8 Global Edaravone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Edaravone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Edaravone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Edaravone Market by Type
  1. 4.1 Edaravone Type Introduction
  2. 4.1.1 Oral Edaravone
  3. 4.1.2 Injection Edaravone
  4. 4.2 Global Edaravone Sales Volume by Type
  5. 4.2.1 Global Edaravone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Edaravone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Edaravone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Edaravone Sales Value by Type
  9. 4.3.1 Global Edaravone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Edaravone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Edaravone Sales Value Share by Type (2021-2032)
5 Edaravone Market by Application
  1. 5.1 Edaravone Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Edaravone Sales Volume by Application
  6. 5.2.1 Global Edaravone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Edaravone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Edaravone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Edaravone Sales Value by Application
  10. 5.3.1 Global Edaravone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Edaravone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Edaravone Sales Value Share by Application (2021-2032)
6 Edaravone Regional Sales and Value Analysis
  1. 6.1 Global Edaravone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Edaravone Sales by Region (2021-2032)
  3. 6.2.1 Global Edaravone Sales by Region: 2021-2026
  4. 6.2.2 Global Edaravone Sales by Region (2027-2032)
  5. 6.3 Global Edaravone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Edaravone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Edaravone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Edaravone Sales Value by Region (2027-2032)
  9. 6.5 Global Edaravone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Edaravone Sales Value (2021-2032)
  12. 6.6.2 North America Edaravone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Edaravone Sales Value (2021-2032)
  15. 6.7.2 Europe Edaravone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Edaravone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Edaravone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Edaravone Sales Value (2021-2032)
  21. 6.9.2 South America Edaravone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Edaravone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Edaravone Sales Value Share by Country, 2025 VS 2032
7 Edaravone Country-level Sales and Value Analysis
  1. 7.1 Global Edaravone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Edaravone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Edaravone Sales by Country (2021-2032)
  4. 7.3.1 Global Edaravone Sales by Country (2021-2026)
  5. 7.3.2 Global Edaravone Sales by Country (2027-2032)
  6. 7.4 Global Edaravone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Edaravone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Edaravone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Edaravone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Edaravone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Edaravone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Edaravone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Edaravone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Edaravone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Edaravone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Edaravone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Edaravone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Edaravone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Edaravone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Edaravone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Edaravone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Edaravone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Edaravone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Edaravone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Edaravone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Edaravone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Edaravone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Edaravone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Edaravone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Edaravone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Edaravone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Edaravone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Edaravone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Edaravone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Edaravone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Edaravone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Edaravone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Edaravone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Edaravone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Edaravone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Edaravone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Edaravone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Edaravone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Edaravone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Edaravone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Edaravone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Edaravone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Edaravone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Edaravone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Edaravone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Edaravone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Edaravone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Edaravone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Edaravone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Edaravone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Edaravone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Edaravone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Edaravone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Edaravone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Edaravone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Edaravone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Edaravone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Edaravone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Edaravone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Edaravone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Edaravone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Edaravone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Edaravone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Edaravone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Edaravone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Edaravone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Edaravone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Edaravone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Edaravone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Edaravone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Edaravone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Edaravone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Edaravone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Edaravone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Edaravone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Edaravone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Edaravone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Edaravone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Edaravone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Edaravone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Edaravone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Edaravone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Edaravone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Edaravone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Edaravone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Edaravone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Edaravone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Mitsubishi Tanabe Pharma
  2. 8.1.1 Mitsubishi Tanabe Pharma Company Information
  3. 8.1.2 Mitsubishi Tanabe Pharma Business Overview
  4. 8.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Mitsubishi Tanabe Pharma Edaravone Product Portfolio
  6. 8.1.5 Mitsubishi Tanabe Pharma Recent Developments
  7. 8.2 Piramal Healthcare
  8. 8.2.1 Piramal Healthcare Company Information
  9. 8.2.2 Piramal Healthcare Business Overview
  10. 8.2.3 Piramal Healthcare Edaravone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Piramal Healthcare Edaravone Product Portfolio
  12. 8.2.5 Piramal Healthcare Recent Developments
  13. 8.3 Simcere
  14. 8.3.1 Simcere Company Information
  15. 8.3.2 Simcere Business Overview
  16. 8.3.3 Simcere Edaravone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Simcere Edaravone Product Portfolio
  18. 8.3.5 Simcere Recent Developments
  19. 8.4 Sun Pharmaceutical Industries Ltd.
  20. 8.4.1 Sun Pharmaceutical Industries Ltd. Company Information
  21. 8.4.2 Sun Pharmaceutical Industries Ltd. Business Overview
  22. 8.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharmaceutical Industries Ltd. Edaravone Product Portfolio
  24. 8.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  25. 8.5 Taj Pharmaceuticals Ltd.
  26. 8.5.1 Taj Pharmaceuticals Ltd. Company Information
  27. 8.5.2 Taj Pharmaceuticals Ltd. Business Overview
  28. 8.5.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Taj Pharmaceuticals Ltd. Edaravone Product Portfolio
  30. 8.5.5 Taj Pharmaceuticals Ltd. Recent Developments
  31. 8.6 UCB India Ltd
  32. 8.6.1 UCB India Ltd Company Information
  33. 8.6.2 UCB India Ltd Business Overview
  34. 8.6.3 UCB India Ltd Edaravone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 UCB India Ltd Edaravone Product Portfolio
  36. 8.6.5 UCB India Ltd Recent Developments
  37. 8.7 Unichem Laboratories Ltd
  38. 8.7.1 Unichem Laboratories Ltd Company Information
  39. 8.7.2 Unichem Laboratories Ltd Business Overview
  40. 8.7.3 Unichem Laboratories Ltd Edaravone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Unichem Laboratories Ltd Edaravone Product Portfolio
  42. 8.7.5 Unichem Laboratories Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Edaravone Value Chain Analysis
  2. 9.1.1 Edaravone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Edaravone Sales Mode & Process
  6. 9.2 Edaravone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Edaravone Distributors
  9. 9.2.3 Edaravone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst